Stock 1558 YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Equities

1558

CNE1000023R6

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:22 29/04/2024 pm IST 		5-day change 1st Jan Change
13.08 HKD +2.19% Intraday chart for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. +9.36% +37.83%
09/04 Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma MT
01/04 Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 17,593 6,540 4,374 5,052 7,590 10,654 - -
Enterprise Value (EV) 1 17,849 5,031 6,436 7,873 7,590 10,654 10,654 10,654
P/E ratio 9.86 x 14 x -7.42 x 63.8 x 3.82 x - - -
Yield 3.29% 1.35% - - - 8.44% 8.27% 8.95%
Capitalization / Revenue 2.83 x 2.79 x 4.79 x 1.35 x 1.21 x 1.62 x 1.59 x 1.58 x
EV / Revenue 2.83 x 2.79 x 4.79 x 1.35 x 1.21 x 1.62 x 1.59 x 1.58 x
EV / EBITDA 6.87 x 4.75 x -25.2 x 7.23 x 2.76 x 4.62 x 4.42 x 4.51 x
EV / FCF 1,44,42,826 x 2,14,18,312 x - - - - - -
FCF Yield 0% 0% - - - - - -
Price to Book 5.22 x 1.34 x 0.75 x 0.86 x - 1.2 x 1.07 x 0.97 x
Nbr of stocks (in thousands) 8,89,785 8,79,968 8,79,968 8,79,968 8,79,968 8,79,968 - -
Reference price 2 19.77 7.432 4.970 5.741 8.626 11.85 11.85 11.85
Announcement Date 27/03/20 19/03/21 21/03/22 24/03/23 28/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,224 2,348 913.8 3,745 6,295 6,596 6,706 6,745
EBITDA 1 2,560 1,377 -173.5 698.4 2,745 2,304 2,412 2,361
EBIT 1 2,474 1,255 -423.4 321.1 2,354 2,243 2,347 2,293
Operating Margin 39.74% 53.43% -46.33% 8.57% 37.4% 34% 35% 34%
Earnings before Tax (EBT) 2,269 1,010 -667.2 - 2,127 - - -
Net income 1,919 839.5 -587.6 - 1,993 - - -
Net margin 30.83% 35.75% -64.31% - 31.66% - - -
EPS 2.005 0.5300 -0.6700 0.0900 2.260 - - -
Free Cash Flow 1,218 305.3 - - - - - -
FCF margin 19.57% 13% - - - - - -
FCF Conversion (EBITDA) 47.59% 22.17% - - - - - -
FCF Conversion (Net income) 63.49% 36.37% - - - - - -
Dividend per Share 2 0.6500 0.1000 - - - 1.000 0.9800 1.060
Announcement Date 27/03/20 19/03/21 21/03/22 24/03/23 28/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2
Net sales 1 - 2,452
EBITDA - -
EBIT 1 - 220.5
Operating Margin - 8.99%
Earnings before Tax (EBT) - -
Net income -32.8 -
Net margin - -
EPS 2 -0.0400 0.1300
Dividend per Share - -
Announcement Date 26/08/22 24/03/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 256 - 2,062 2,822 - - - -
Net Cash position - 1,509 - - - - - -
Leverage (Debt/EBITDA) 0.1001 x - -11.89 x 4.04 x - - - -
Free Cash Flow 1,218 305 - - - - - -
ROE (net income / shareholders' equity) 48.9% 18.1% -11% 1.31% - 21.7% 20.8% 18.7%
ROA (Net income/ Total Assets) 26.5% 8.62% -5.85% - - - - -
Assets 7,237 9,737 10,051 - - - - -
Book Value Per Share 1 3.790 5.550 6.600 6.690 - 9.890 11.10 12.30
Cash Flow per Share 1.540 1.180 -0.7500 - - - - -
Capex 576 994 356 - - - - -
Capex / Sales 9.26% 42.34% 38.99% - - - - -
Announcement Date 27/03/20 19/03/21 21/03/22 24/03/23 28/03/24 - - -
1CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.85 CNY
Average target price
12.94 CNY
Spread / Average Target
+9.22%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. Stock YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
+37.83% 1.44B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.17% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.66% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.00% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.69% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-5.22% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1558 Stock
  4. Financials YiChang HEC ChangJiang Pharmaceutical Co., Ltd.